secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2026-08-06T20:04:00+00:00
Accession:  0001628280-26-054274
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q2 net income $65.8M vs loss $17.7M YoY; revenue down 13.6%
------------------------------------------------------------------------

- Diluted EPS $9.38 vs $(2.95) in Q2 2025; six-month net income $112.6M, EPS $15.87.
- Revenue $210.8M (-13.6% YoY) due to prior-year IDR benefits; hospital visits +9.6%.
- Adjusted EBITDA $90.0M vs $71.6M; operating cash flow $34.2M vs $27.3M.
- HaloMD amendment and CMS fee cut reduced contract services by $52.3M; expects 25-30% ongoing savings.
- Cash $205.2M, long-term debt $31.1M; three new hospitals expected to open in H2 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000162828026054274/0001628280-26-054274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000162828026054274/nutx-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-054274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer